Cargando…

Integrins as Therapeutic Targets for SARS-CoV-2

Detalles Bibliográficos
Autores principales:	Gressett, Timothy E., Nader, Danielle, Robles, Juan Pablo, Buranda, Tione, Kerrigan, Steven W., Bix, Gregory
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128570/ https://www.ncbi.nlm.nih.gov/pubmed/35619646 http://dx.doi.org/10.3389/fcimb.2022.892323

Ejemplares similares

Integrin activation is an essential component of SARS-CoV-2 infection
por: Simons, Peter, et al.
Publicado: (2021)

Can the SARS-CoV-2 Spike Protein Bind Integrins Independent of the RGD Sequence?
por: Beaudoin, Christopher A., et al.
Publicado: (2021)

SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development
por: Wang, Mei-Yue, et al.
Publicado: (2020)

Human endothelial cell-derived exosomal microRNA-99a/b drives a sustained inflammatory response during sepsis by inhibiting mTOR expression
por: Fitzpatrick, Glenn, et al.
Publicado: (2022)

Metabolic Implications of Oxidative Stress and Inflammatory Process in SARS-CoV-2 Pathogenesis: Therapeutic Potential of Natural Antioxidants
por: Forcados, Gilead Ebiegberi, et al.
Publicado: (2021)

Drug-induced phospholipidosis is not correlated with the inhibition of SARS-CoV-2 - inhibition of SARS-CoV-2 is cell line-specific
por: Diesendorf, Viktoria, et al.
Publicado: (2023)

Occurrence of SARS-CoV-2 reinfections at regular intervals in Ecuador
por: Guevara, Rommel, et al.
Publicado: (2022)

Effect of acetic acid inactivation of SARS-CoV-2
por: Amruta, Narayanappa, et al.
Publicado: (2023)

SARS-CoV-2: The Monster Causes COVID-19
por: Song, Chang, et al.
Publicado: (2022)

SARS-CoV-2: Origin, Evolution, and Targeting Inhibition
por: Ning, Shuo, et al.
Publicado: (2021)

Distinct Metagenomic Signatures in the SARS-CoV-2 Infection
por: Liu, Yijun, et al.
Publicado: (2021)

Novel Lateral Flow-Based Assay for Simple and Visual Detection of SARS-CoV-2 Mutations
por: Gomez-Martinez, Julien, et al.
Publicado: (2022)

Characterization of the Interaction Between SARS-CoV-2 Membrane Protein (M) and Proliferating Cell Nuclear Antigen (PCNA) as a Potential Therapeutic Target
por: Zambalde, Érika Pereira, et al.
Publicado: (2022)

SARS-CoV-2 in Pregnant Women: Consequences of Vertical Transmission
por: Chaubey, Ishaan, et al.
Publicado: (2021)

SARS-CoV-2 Infects Endothelial Cells In Vivo and In Vitro
por: Liu, Fengming, et al.
Publicado: (2021)

SARS-CoV-2: Emergence of New Variants and Effectiveness of Vaccines
por: Singh, Desh Deepak, et al.
Publicado: (2021)

microRNA, the Innate-Immune System and SARS-CoV-2
por: Hill, James M., et al.
Publicado: (2022)

SARS-CoV-2 induced hepatic injuries and liver complications
por: Saeed, Umar, et al.
Publicado: (2022)

Choosing a cellular model to study SARS-CoV-2
por: Pires De Souza, Gabriel Augusto, et al.
Publicado: (2022)

Withania somnifera (L.) Dunal (Ashwagandha) for the possible therapeutics and clinical management of SARS-CoV-2 infection: Plant-based drug discovery and targeted therapy
por: Singh, Manali, et al.
Publicado: (2022)

Functional Pangenome Analysis Shows Key Features of E Protein Are Preserved in SARS and SARS-CoV-2
por: Alam, Intikhab, et al.
Publicado: (2020)

In silico analysis of SARS-CoV-2 genomes: Insights from SARS encoded non-coding RNAs
por: Periwal, Neha, et al.
Publicado: (2022)

Improving Detection Efficiency of SARS-CoV-2 Nucleic Acid Testing
por: Zhang, Jie, et al.
Publicado: (2020)

Characteristics of COVID-19 Patients With SARS-CoV-2 Positivity in Feces
por: Wu, Wenrui, et al.
Publicado: (2022)

SARS CoV-2 Nucleoprotein Enhances the Infectivity of Lentiviral Spike Particles
por: Mishra, Tarun, et al.
Publicado: (2021)

Deleterious Effects of SARS-CoV-2 Infection on Human Pancreatic Cells
por: Shaharuddin, Syairah Hanan, et al.
Publicado: (2021)

Corrigendum: SARS-CoV-2: Emergence of New Variants and Effectiveness of Vaccines
por: Singh, Desh Deepak, et al.
Publicado: (2022)

Evidence of Infection of Human Embryonic Stem Cells by SARS-CoV-2
por: Zeng, Weijie, et al.
Publicado: (2022)

The Differentiation and Maintenance of SARS-CoV-2-Specific Follicular Helper T Cells
por: Wang, Yifei, et al.
Publicado: (2022)

Imaging Techniques: Essential Tools for the Study of SARS-CoV-2 Infection
por: Deroubaix, Aurélie, et al.
Publicado: (2022)

The Relationship Between Pediatric Gut Microbiota and SARS-CoV-2 Infection
por: Romani, Lorenza, et al.
Publicado: (2022)

Inflammasomes during SARS-CoV-2 infection and development of their corresponding inhibitors
por: Diarimalala, Rominah Onintsoa, et al.
Publicado: (2023)

Host mitochondria: more than an organelle in SARS-CoV-2 infection
por: Shoraka, Shahrzad, et al.
Publicado: (2023)

Regulation of SARS-CoV-2 infection by diet-modulated gut microbiota
por: Tieu, Vivian, et al.
Publicado: (2023)

FOXO1 inhibits FSL-1 regulation of integrin β6 by blocking STAT3 binding to the integrin β6 gene promoter
por: Xu, Mingyan, et al.
Publicado: (2022)

SARS-CoV-2 Membrane Glycoprotein M Triggers Apoptosis With the Assistance of Nucleocapsid Protein N in Cells
por: Ren, Yujie, et al.
Publicado: (2021)

Unraveling the Epidemiology, Geographical Distribution, and Genomic Evolution of Potentially Lethal Coronaviruses (SARS, MERS, and SARS CoV-2)
por: Masood, Nosheen, et al.
Publicado: (2020)

Editorial: Lectins from plants, algae, fungi, bacteria and animal therapeutic tools for SARS-CoV-2 and other pathogenic enveloped viruses, in a “one-health” perspective
por: Van Damme, Els J. M., et al.
Publicado: (2023)

Is the “Common Cold” Our Greatest Ally in the Battle Against SARS-CoV-2?
por: Capoor, Manu N., et al.
Publicado: (2020)

IgA Antibodies and IgA Deficiency in SARS-CoV-2 Infection
por: Quinti, Isabella, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_b5gs72s093726uhdpj878gq898